Experimental Hematology
Volume 37, Issue 7 , Pages 849-856 , July 2009

Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: A novel organization for these secreted proteins

  • Julien Villeneuve

      Affiliations

    • INSERM U889 and Université Victor Segalen Bordeaux 2, France
    • Drs. Villeneuve and Block are considered as joint first authors of this work.
    • ,
  • Anna Block

      Affiliations

    • French National Reference Center for Platelet Disorders, Hôpital Xavier Arnozan, Pessac, France
    • Drs. Villeneuve and Block are considered as joint first authors of this work.
    • ,
  • Marie-Caroline Le Bousse-Kerdilès

      Affiliations

    • INSERM U972, Hôpital Paul Brousse and Université Paris-Sud, Institut André Lwoff, Villejuif, France
    • ,
  • Sébastien Lepreux

      Affiliations

    • INSERM U889 and Université Victor Segalen Bordeaux 2, France
    • ,
  • Paquita Nurden

      Affiliations

    • French National Reference Center for Platelet Disorders, Hôpital Xavier Arnozan, Pessac, France
    • ,
  • Jean Ripoche

      Affiliations

    • INSERM U889 and Université Victor Segalen Bordeaux 2, France
    • ,
  • Alan T. Nurden

      Affiliations

    • French National Reference Center for Platelet Disorders, Hôpital Xavier Arnozan, Pessac, France
    • Corresponding Author InformationOffprint requests to: Alan T. Nurden, Ph.D., Centre de Référence des Pathologies Plaquettaires, Plateforme Technologique et d'Innovation Biomédicale, Hôpital Xavier Arnozan, 33604 Pessac, France

Received 17 February 2009 ,Revised 25 March 2009 ,Accepted 26 March 2009.

References 

  1. Weyrich AS, Prescott SM, Zimmerman GA. Platelets, endothelial cells, inflammatory chemokines and restenosis. Complex signaling in the vascular playbook. Circulation. 2002;10:1433–1435
  2. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 2007;100:27–40
  3. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3525–3548
  4. Coppinger JA, O'Connor R, Wynne K, et al. Moderation of the platelet releasate response by aspirin. Blood. 2007;109:4796–4792
  5. Reed GL. Platelet secretory mechanisms. Semin Thromb Hemost. 2004;30:441–450
  6. Sehgal S, Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost. 2007;5:2008–2016
  7. Ma L, Perini R, McKnight W, et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci U S A. 2005;102:216–220
  8. Italiano JE, Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and anti-angiogenic proteins are organized into separate platelet α-granules and differentially released. Blood. 2007;111:1227–1233
  9. Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res. 2008;121:535–542
  10. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature. 1997;386:616–619
  11. Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost. 1998;80:836–839
  12. Sheu JR, Fong TH, Liu CM, et al. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol. 2004;143:193–201
  13. Fernandez-Patron C, Martinez-Cuesta MA, Salas E, et al. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost. 1999;82:1730–1735
  14. Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol. 2007;27:1511–1520
  15. Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIb shedding from platelets in vitro and in vivo. Circ Res. 2004;95:677–683
  16. Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem. 2005;280:14462–14468
  17. Lambert E, Dassé E, Haye B, Petitfrère E. TIMPs as multifacial proteins. Clin Rev Hematol Oncol. 2004;49:187–198
  18. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827–839
  19. Radomski A, Jurasz P, Sanders EJ, et al. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br J Pharmacol. 2002;137:1330–1338
  20. Kazes I, Elalamy I, Sraer J-D, Hatmi M, Nguyen G. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood. 2000;96:3064–3069
  21. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev. 2007;21:31–36
  22. Nurden P, Jandrot-Perrus M, Combrié R, et al. Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. Blood. 2004;104:107–114
  23. Fugman DA, Witte DP, Jones BJ, Aronow BW, Lieberman MA. In vitro establishment and characterization of a human megakaryoblastic cell line. Blood. 1990;75:1252–1261
  24. Choi WS, Jeon OH, Kim HH, Kim DS. MMP-2 regulates human platelet activation by interacting with integrin αIIbβ3. J Thromb Haemost. 2008;6:517–523
  25. Galt GW, Lindemann S, Allen L, et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res. 2002;90:1093–1099
  26. Gardiner EE, Karunakaran D, Arthur JF, et al. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcγRIIa. Blood. 2008;111:165–174
  27. Klinger MH, Jelkmann W. Subcellular localization of thrombopoietin in human blood platelets and its release upon thrombin stimulation. Br J Haematol. 2001;115:421–427
  28. Handagamma P, Scarborough RM, Shuman MA, Bainton DF. Endocytosis of fibrinogen into megakaryocyte and platelet alpha granules is mediated by αIIbβ3 (glycoprotein IIb-IIIa). Blood. 1993;82:135–138
  29. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood. 2003;101:2285–2293
  30. Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005;122:379–391
  31. Murate T, Yamashita K, Isogai C, et al. The production of tissue inhibitors of metalloproteinases [TIMPs] in megakaryopoiesis: possible role of platelet- and megakaryocyte- derived TIMPs in bone marrow fibrosis. Br J Haematol. 1997;99:181–189
  32. Marquez-Curtis LA, Dobrowsky A, Montano J, et al. Matrix metalloproteases and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukemic long-term marrow cultures. Br J Haematol. 2001;115:595–604
  33. Heijnen HF, Debili N, Vainchenker W, Breton-Gorius J, Geuze HJ, Sixma JJ. Multivesicular bodies are an intermediate stage in the formation of platelet α-granules. Blood. 1998;91:2313–2325
  34. Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood. 1985;66:1309–1316
  35. Nurden AT, Nurden P, Bermejo E, Combrié R, McVicar DW, Washington V. Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1. Thromb Haemost. 2008;100:45–51
  36. Rendu F. Brohard-Bohn B The platelet release reaction: granules' constituents, secretion and function. Platelets. 2001;12:261–273
  37. White JG. Ultrastructural studies of the gray platelet syndrome. Am J Pathol. 1979;95:445–462
  38. Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J. Defective α-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol. 1981;102:10–19
  39. Sadler JE. Von willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008;112:11–18

PII: S0301-472X(09)00115-5

doi: 10.1016/j.exphem.2009.03.009

Experimental Hematology
Volume 37, Issue 7 , Pages 849-856 , July 2009

Article Tools

* Image Usage & Resolution